Clinical Trial

Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a pre-surgical study involving subjects with local advanced bladder cancer, who are candidates for neoadjuvant therapy. It is a single-arm phase II portion.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-04-26; most recent amendment 2024-11-30.
Status change: Not Yet Recruiting → Recruiting 2021-06-09
Trial Details
NCT Number NCT04861584
Lead Sponsor Zhujiang Hospital
Conditions Urinary Bladder Cancer
Enrollment 41 participants
Start Date 2021-06-03
Primary Completion 2026-10-03 (estimated)
Study Completion 2027-04-03 (estimated)
Updated on ClinicalTrials.gov 2024-12-04